journal
MENU ▼
Read by QxMD icon Read
search

Urologic Oncology

journal
https://www.readbyqxmd.com/read/29307598/high-perirenal-fat-thickness-predicts-a-poor-progression-free-survival-in-patients-with-localized-clear-cell-renal-cell-carcinoma
#1
Haichao Huang, Shi Chen, Wei Li, Xiurong Wu, Jinchun Xing
OBJECTIVES: The aim of the study was to assess the association between the progression-free survival (PFS) and perirenal fat thickness (PFT) in a population of histopathologically confirmed, localized clear cell renal cell carcinoma (ccRCC) patients. METHODS: We retrospectively enrolled 174 patients with localized ccRCC at our center between December 2009 and December 2015. The preoperative visceral fat area (VFA), PFT, and subcutaneous fat area (SFA) were evaluated...
January 4, 2018: Urologic Oncology
https://www.readbyqxmd.com/read/29306557/penile-cancer-sparing-surgery-the-balance-between-oncological-cure-and-functional-preservation
#2
Kevin R Loughlin
Penile cancer presents the dual challenge of achieving oncological cure while ,simultaneously, attempting to preserve sexual function. Herein is a review of the issues involved in appropriate patient selection as well as surgical technique. Recommendations regarding follow up and monitoring are also provided.
January 3, 2018: Urologic Oncology
https://www.readbyqxmd.com/read/29306556/sarcomatoid-renal-cell-carcinoma-biology-and-treatment-advances
#3
REVIEW
Nemer El Mouallem, Steven C Smith, Asit K Paul
Sarcomatoid transformation in renal cell carcinoma, so called sacromatoid RCC (sRCC), is associated with an aggressive behavior and a poor prognosis. Current therapeutic approaches are largely ineffective. Recent studies looking into the genomic and molecular characterization of sRCCs have provided insights into the biology and pathogenesis of this entity. These advances in molecular signatures may help development of effective treatment strategies. We herein present a review of recent developments in the pathology, biology, and treatment modalities in sRCC...
January 3, 2018: Urologic Oncology
https://www.readbyqxmd.com/read/29289429/synaptophysin-expression-on-circulating-tumor-cells-in-patients-with-castration-resistant-prostate-cancer-undergoing-treatment-with-abiraterone-acetate-or-enzalutamide
#4
Sumanta K Pal, Miaoling He, Lin Chen, Lixin Yang, Raju Pillai, Przemyslaw Twardowski, JoAnn Hsu, Marcin Kortylewski, Jeremy O Jones
BACKGROUND: With the advent of secondary androgen receptor (AR)-targeted therapies in metastatic castration resistant prostate cancer (PC), nonadenocarcinoma PCs are becoming more prevalent. Many of these cancers express neuroendocrine markers, which may provide biomarkers for emergence of this disease state. We aimed to quantify the expression of synaptophysin (Syp) on circulating tumor cells (CTCs) from serial samples of patients being treated with abiraterone acetate or enzalutamide...
December 27, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29288008/usage-and-survival-implications-of-surgical-staging-of-inguinal-lymph-nodes-in-intermediate-to-high-risk-clinical-localized-penile-cancer-a-propensity-score-matched-analysis
#5
Solomon L Woldu, Bo Ci, Ryan C Hutchinson, Laura-Maria Krabbe, Nirmish Singla, Niccolo M Passoni, Timothy N Clinton, Ganesh V Raj, David S Miller, Arthur I Sagalowsky, Yair Lotan, Yang Xie, Vitaly Margulis, Aditya Bagrodia
OBJECTIVES: To evaluate the usage of surgical staging of inguinal lymph nodes (SSILNs) in the United States for intermediate to high-risk, clinically localized penile squamous cell cancer (SCC), to explore patient and hospital factors associated with omission of this staging, and to evaluate the effect on survival. PATIENTS AND METHODS: Retrospective, observational study using the National Cancer Database from 2004 to 2014 of 1,689 men diagnosed with pT1b-T3, cN0 penile SCC, who by current guidelines should receive SSILNs-either by inguinal lymph node (ILN) dissection or sentinel node biopsy...
December 26, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29288007/overexpression-of-semaphorin-3a-in-patients-with-urothelial-cancer
#6
Zahava Vadasz, Jacob Rubinstein, Jacob Bejar, Hilla Sheffer, Sarel Halachmi
OBJECTIVE: A highly sensitive and specific urine marker for the detection of recurrent urothelial cancer and for screening healthy population or people at risk for urothelial cancer has not been found yet. As urine cytology is not sensitive enough, patients with non-muscle-invasive bladder cancer need lifelong follow-up involving multiple invasive cystoscopies. Our aims of study were to examine the expression of semaphorin 3A in urothelial cancer patients and to evaluate semaphorin 3A as a potential marker for urothelial cancer...
December 26, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29288006/advancements-in-optical-techniques-and-imaging-in-the-diagnosis-and-management-of-bladder-cancer
#7
REVIEW
Tracy L Rose, Yair Lotan
Accurate detection and staging is critical to the appropriate management of urothelial cancer (UC). The use of advanced optical techniques during cystoscopy is becoming more widespread to prevent recurrent nonmuscle invasive bladder cancer. Standard of care for muscle-invasive UC includes the use of computed tomography and/or magnetic resonance imaging, but staging accuracy of these tests remains imperfect. Novel imaging modalities are being developed to improve current test performance. Positron emission tomography/computed tomography has a role in the initial evaluation of select patients with muscle-invasive bladder cancer and in disease recurrence in some cases...
December 26, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29288005/ex-vivo-culture-of-tumor-cells-from-n-methyl-n-nitrosourea-induced-bladder-cancer-in-rats-development-of-organoids-and-an-immortalized-cell-line
#8
Takahiro Yoshida, Max Kates, Nikolai A Sopko, Xiaopu Liu, Alok K Singh, William R Bishai, Gregory Joice, David J McConkey, Trinity J Bivalacqua
OBJECTIVE: We ex vivo cultured primary tumor cells from N-methyl-N-nitrosourea (MNU)-induced bladder tumors in rats and established an immortalized cell line from them. MATERIALS AND METHODS: Bladder tumors in rats were induced by instillation of MNU into the murine bladder. Primary tumor cells were prepared by the cancer-tissue originated spheroid method. An immortalized cell line was established by co-culture with fibroblasts. The cultured tumor cells were molecularly and functionally characterized by quantitative real-time polymerase chain reaction, Western blot, growth assay, and transwell migration assay...
December 26, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29288004/targeted-antimicrobial-prophylaxis-for-transrectal-ultrasound-guided-prostate-biopsy-during-active-surveillance-effect-on-hospitalization
#9
Carling Cheung, Hiten D Patel, Patricia Landis, H Ballentine Carter, Misop Han
OBJECTIVES: We investigated the effect of targeted antibiotic prophylaxis using rectal swab cultures on hospitalization for infectious complications after transrectal ultrasound-guided prostate biopsy (TRUSP). MATERIALS AND METHODS: A cohort of men (1995-2016) with prostate cancer on active surveillance receiving annual TRUSP biopsies was surveyed to determine the incidence of hospitalization for suspected postbiopsy sepsis. We compared biopsy events (i.e., unique biopsies) in the era of empiric prophylaxis to those in the era of targeted prophylaxis based on culture...
December 26, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29288003/tertiary-gleason-pattern-in-radical-prostatectomy-specimens-is-associated-with-worse-outcomes-than-the-next-higher-gleason-score-group-in-localized-prostate-cancer
#10
Mehmet Özsoy, David D'Andrea, Marco Moschini, Beat Foerster, Mohammad Abufaraj, Romain Mathieu, Alberto Briganti, Pierre I Karakiewicz, Morgan Roupret, Christian Seitz, Anna Katarzyna Czech, Martin Susani, Shahrokh F Shariat
AIM: To assess the predictive value of TGP on biochemical recurrence (BCR) and its association with clinicopathological outcomes in a large, multicenter cohort of patients with localized prostate cancer (PCa) treated with radical prostatectomy (RP). MATERIALS AND METHODS: Records of 6,041 patients who were treated with RP between 2000 and 2011 for clinically nonmetastatic PCa were, retrospectively, analyzed from prospectively collected datasets. BCR-free survival rates were assessed using univariable and multivariable cox-regression analyses...
December 26, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29288002/m2-macrophage-infiltration-and-macrophage-traits-of-tumor-cells-in-urinary-bladder-cancer
#11
Firas Aljabery, Hans Olsson, Oliver Gimm, Staffan Jahnson, Ivan Shabo
BACKGROUND: Tumor-associated macrophages (TAMs) constitute a subset of nonneoplastic cells in tumor stroma and influence cancer progression in solid tumors. The clinical significance of TAMs in urinary bladder cancer (UBC) is controversial. METHODS: We prospectively studied 103 patients with stage pT1-T4 UBC treated with cystectomy and pelvic lymph node dissection. Tumor sections were immunostained with M2-specific macrophage marker CD163 and proliferation marker Ki-67...
December 26, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29277585/a-comparison-of-time-taken-to-return-to-baseline-erectile-function-following-focal-and-whole-gland-ablative-therapies-for-localized-prostate-cancer-a-systematic-review
#12
REVIEW
Nicholas A Faure Walker, Joseph M Norris, Taimur T Shah, Tet Yap, Paul Cathcart, Caroline M Moore, Hashim U Ahmed, Mark Emberton, Suks Minhas
OBJECTIVES: To systematically review erectile function (EF) outcomes following primary whole gland (WG) and focal ablative therapies for localized prostate cancer to ascertain whether the treatment modality or intended treatment volume affects the time taken to recover baseline EF. METHOD AND MATERIALS: A systematic review was performed according to the preferred reporting items for systematic review and meta-analysis statement. Inclusion criteria were men with localized prostate cancer treated with primary, ablative therapy...
December 22, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29277584/comparative-effectiveness-of-robot-assisted-vs-open-radical-cystectomy
#13
Nawar Hanna, Jeffrey J Leow, Maxine Sun, David F Friedlander, Thomas Seisen, Firas Abdollah, Stuart R Lipsitz, Mani Menon, Adam S Kibel, Joaquim Bellmunt, Toni K Choueiri, Quoc-Dien Trinh
OBJECTIVES: Over the past decade, robot-assisted radical cystectomy (RARC) has gained traction as an alternative to the conventional open approach open radical cystectomy (ORC). However, the benefits of RARC over ORC remain unclear. Our objective was to conduct a comparative effectiveness analysis between RARC and ORC using data from the National Cancer Data Base. MATERIALS AND METHODS: Within the National Cancer Data Base, we identified patients with localized muscle-invasive bladder cancer who underwent RC between 2010 and 2013...
December 22, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29277583/wisp1-genetic-variants-as-predictors-of-tumor-development-with-urothelial-cell-carcinoma
#14
Hsiang-Lin Lee, Hui-Ling Chiou, Shian-Shiang Wang, Sheng-Chun Hung, Ming-Chih Chou, Shun-Fa Yang, Ming-Ju Hsieh, Ying-Erh Chou
OBJECTIVES: Urothelial cell carcinoma (UCC) of the urinary bladder is a major malignancy of the genitourinary tract. Etiological factors, such as the environment, ethnicity, genetics, and diet, contribute to UCC carcinogenesis. WNT1-inducible signaling pathway protein 1 (WISP1), also known as CCN4, a cysteine-rich protein belonging to the Cyr61, CTGF, Nov (CCN) family of matricellular proteins, has many developmental functions and might be involved in carcinogenesis. This study investigated WISP1 single-nucleotide polymorphisms to evaluate UCC susceptibility and clinicopathological characteristics...
December 22, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29276063/is-sarcopenia-and-sarcopenic-obesity-associated-with-clinical-and-pathological-outcomes-in-patients-undergoing-radical-nephroureterectomy
#15
Neil J Kocher, Syed Jafri, Samyuktha Balabhadra, Erik Lehman, Jacob Gardner, Kanupriya Vijay, Nabeel Sarwani, Jay D Raman
PURPOSE: To investigate the association between sarcopenia and sarcopenic obesity on clinical, perioperative, and oncologic outcomes in patients with upper-tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy (RNU). METHODS: Retrospective review of our institutional UTUC database was performed to identify all patients who underwent radical nephroureterectomy from 2002-2016. Skeletal Muscle Index (SMI) was measured at the L3 vertebral level and standardized according to patient height (cm2/m2)...
December 21, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29276062/targeting-urothelial-carcinoma-cells-by-combining-cisplatin-with-a-specific-inhibitor-of-the-autophagy-inducing-class-iii-ptdins3k-complex
#16
David Schlütermann, Margaretha A Skowron, Niklas Berleth, Philip Böhler, Jana Deitersen, Fabian Stuhldreier, Nora Wallot-Hieke, Wenxian Wu, Christoph Peter, Michèle J Hoffmann, Günter Niegisch, Björn Stork
BACKGROUND: Cisplatin-based regimens are routinely employed for the treatment of urothelial carcinoma. However, therapeutic success is hampered by the primary presence of or the development of cisplatin resistance. This chemoresistance is executed by multiple cellular pathways. In recent years, the cellular process of autophagy has been identified as a prosurvival pathway of cancer cells. On the one hand, autophagy enables cancer cells to survive conditions of low oxygen or nutrient supply, frequently found in tumors...
December 21, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29276061/relationship-between-abo-blood-group-and-outcome-in-patients-with-upper-tract-urothelial-carcinoma-treated-with-radical-nephroureterectomy
#17
LETTER
Bo Cheng, Xiao-Fu Qiu, Qi-Dan He, Guo-Sheng Yang
No abstract text is available yet for this article.
December 21, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29276060/brachytherapy-monotherapy-may-be-sufficient-for-a-subset-of-patients-with-unfavorable-intermediate-risk-prostate-cancer
#18
Martin T King, Ming-Hui Chen, Brian J Moran, Michelle H Braccioforte, Ivan Buzurovic, Vinayak Muralidhar, David D Yang, Kent W Mouw, Phillip M Devlin, Anthony V D'Amico, Paul L Nguyen, Peter F Orio
PURPOSE/OBJECTIVE(S): Brachytherapy (BT) monotherapy is a well-established treatment modality for favorable intermediate risk (FIR) prostate cancer. However, patients with unfavorable intermediate risk (UIR) disease are often recommended trimodality therapy involving BT, androgen deprivation therapy (ADT), and external beam radiation therapy (EBRT). We sought to investigate the relative benefit of supplemental therapies (ADT and/or EBRT) for FIR and UIR prostate cancer in a large dataset...
December 21, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29273351/to-oophorectomy-or-not-to-oophorectomy-practice-patterns-among-urologists-treating-bladder-cancer
#19
Rachael D Sussman, Chihun J Han, Daniel Marchalik, Filipe L Carvahlo, Meghan F Davis, Lee A Richter, Stephanie L Wethington, Lambros Stamatakis
OBJECTIVES: Classically, radical cystectomy (RC) involves hysterectomy and bilateral salpingo-oophorectomy (BSO). Current understanding of ovarian cancer pathogenesis and effect of premature oophorectomy has lead to a shift within gynecology toward risk-reducing salpingectomy without oophorectomy in the absence of gynecologic malignancy. The purpose of this study was to assess knowledge base and practice patterns of urologic oncologists with regard to management of the gynecological organs at the time of RC...
December 19, 2017: Urologic Oncology
https://www.readbyqxmd.com/read/29273350/the-association-of-age-with-perioperative-morbidity-and-mortality-among-men-undergoing-radical-prostatectomy
#20
Jorge F Pereira, Dragan Golijanin, Gyan Pareek, Ruiting Guo, Zheng Zhang, Joseph Renzulli, Boris Gershman M D
INTRODUCTION: Older age is considered a relative contraindication to radical prostatectomy (RP). However, data are limited regarding the impact of age on perioperative outcomes following RP. We examined the association of age with perioperative outcomes following RP to inform risk-stratification and management. MATERIALS AND METHODS: We identified 35,968 men aged 18 to 89 years who underwent RP from 2010 to 2015 in the National Surgical Quality Improvement Program (NSQIP) database...
December 19, 2017: Urologic Oncology
journal
journal
32958
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"